Veonet
Veonet is a Munich-based ophthalmology group operating a multi-country network of eye care clinics in Europe, delivering cataract, glaucoma, retinal, and pediatric services to patients on a direct-to-consumer basis with 2.5 million annual consultations.
- Company typePrivate
- Founded2021
- HeadquartersMünchen, Germany
- Headcount1,001–5,000
- GTM typeB2C
- OfferingServices
What Veonet does
Veonet GmbH is a Munich-headquartered ophthalmology group operating a network of eye care clinics across Europe. The company provides a full spectrum of ophthalmology services — cataract surgery, glaucoma treatment, retinal care, and paediatric ophthalmology — delivered through physical clinic locations on a direct-to-consumer basis. Veonet reports 2.5 million consultations and 0.7 million procedures annually, making it one of the largest dedicated ophthalmology platforms in Europe by patient throughput. The company expanded significantly in 2022 with the acquisition of Miranza, a leading Spanish ophthalmology clinic group, in a transaction valued at more than €250 million, giving Veonet a multi-country footprint spanning Germany, Spain, and (as of 2025) the Republic of Ireland.
Veonet's core technology stack centers on clinical ophthalmology delivery augmented by digitalisation initiatives, most notably RetinSight AI for digital retinal imaging analysis. The platform supports a multi-specialty clinical model with a Medical Board, research and innovation programs, and active participation in international congresses such as ESCRS 2024. Revenue is generated per-procedure and per-consultation (professional-services model) with quote-based pricing; the group employs between 1,001 and 5,000 people across its European operations.
The business is led by Group CEO Sebastian James, who joined in mid-2024 from a senior role at Boots, with Judith Barth serving as Group CFO. Veonet is privately held with no public listing, and ownership beyond the historical Magnum Industrial Partners stake in Miranza is not publicly disclosed. Recent strategic emphasis has been on geographic expansion (Ireland greenfield), AI-enabled diagnostic capability, and integration of the Miranza platform across European markets.
Veonet firmographics
Firmographics- Name
- Veonet
- Legal name
- Veonet GmbH
- Website
- https://veonet-group.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Veonet is a Munich-based ophthalmology group operating a multi-country network of eye care clinics in Europe, delivering cataract, glaucoma, retinal, and pediatric services to patients on a direct-to-consumer basis with 2.5 million annual consultations.
- Ownership category
- akta.pro rank
Veonet industry classification
Industry- Product category
- Ophthalmology Healthcare Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), Offices of Optometrists (621320), Diagnostic Imaging Centers (621512)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
- akta.pro primary industry
- Ophthalmology Clinics (Medical & Surgical Eye Care) (HLAKAKAC)
- akta.pro secondary industries
- Ophthalmology Surgery Centers (HLAFAIAF), Retina & Vitreous Specialists (HLAKAKAE), Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN)
Keywords
Where Veonet is headquartered
LocationHeadquarters
- HQ city
- München
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Veonet business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Ophthalmology Healthcare Services: Revenue generated from providing eye care services including cataract surgery, glaucoma treatment, retinal care, and paediatric ophthalmology. Services are delivered through clinic-based consultations and procedures.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Medical consultation and procedure services |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Veonet product offering
Product offeringCore offering
Veonet operates a Europe-wide network of eye care clinics providing a full spectrum of ophthalmology services to individual patients, including cataract surgery, glaucoma treatment, retinal care, and paediatric ophthalmology. The group delivers over 2.5 million consultations and 0.7 million surgical and treatment procedures per year through its clinic-based model, and supports clinical practice with AI-assisted diagnostic technology such as RetinSight AI.
Product overview
Veonet is Europe’s leading ophthalmology group providing a unified, full-spectrum eye care platform offering cataract surgery, glaucoma treatment, retinal care, and paediatric ophthalmology services. The company integrates advanced technology and clinical expertise across its markets, delivering over 2.5 million consultations and 0.7 million procedures annually through its network of clinics. The four named services represent the core clinical offerings within Veonet's single integrated healthcare delivery platform, which operates across multiple European countries including Germany, Spain (via the acquired Miranza group), and the Republic of Ireland.
Differentiator
Problem solved
Functional benefit
Products and services
- Cataract Surgery Surgical procedure to remove and replace the natural lens of the eye that has become clouded, restoring clear vision for patients.
- Glaucoma Treatment Medical and surgical interventions to manage intraocular pressure and prevent optic nerve damage leading to vision loss.
- Retinal Care Specialized diagnostics and treatments for conditions affecting the retina, including diabetic retinopathy, macular degeneration, and retinal detachment.
- Paediatric Ophthalmology Eye care services specialized for children, addressing developmental vision issues, strabismus, amblyopia, and other pediatric eye conditions.
Quantifiable outcome
- 2.5 million consultations per year
- +1 more outcomes
Companies that use Veonet
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
Veonet technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Veonet partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- MiranzacoreVeonet acquired Miranza, a leading ophthalmology clinic group in Spain, in a transaction valued at more than €250 million. The acquisition includes continuity of all existing Miranza staff and operations. This acquisition significantly expanded Veonet's presence in the Spanish market.
Scale indicators5 records
Recent moves7 records
Expansion highlights5 records
Veonet competitors and assessment
Company assessmentBroad incumbents
- Carl Zeiss Meditec: Global leader in ophthalmic diagnostic and surgical devices (slit lamps, OCT, surgical microscopes) — broader incumbent in ophthalmology whose installed equipment base is the platform Veonet's RetinSight AI often integrates with.
- Alcon: Global ophthalmic medical device and pharmaceutical company providing IOLs, surgical equipment, and pharmaceuticals — broader incumbent whose products are used inside Veonet's surgical theatres.
- Moorfields Eye Hospital NHS Foundation Trust: One of the world's oldest and largest dedicated ophthalmic hospitals, offering comprehensive medical and surgical eye care — broader incumbent in specialty ophthalmic hospital services overlapping Veonet's clinical scope.
- Bausch + Lomb: Global ophthalmic device, pharmaceutical, and consumer eye-health company — broader incumbent with overlapping surgical and vision-care product portfolio.
Direct peers
- Optimax: UK-based laser eye surgery and lens replacement clinic chain — comparable consumer-direct ophthalmology services operator with a multi-clinic footprint across Europe.
- Clinica Baviera: Leading Spanish ophthalmology clinic chain (part of the Baviera group) offering refractive surgery, cataract, glaucoma, and retinal care — direct peer given Veonet's Spanish footprint via the Miranza acquisition.
- Optical Express: Pan-European ophthalmology and refractive surgery provider operating high-volume clinics offering cataract surgery, lens replacement, and laser eye treatments — closely comparable retail-style clinic model and consumer-direct GTM.
- Groupe Point Vision: French ophthalmology clinic network with 60+ centers providing cataract, glaucoma, and refractive surgery — direct European peer with similar multi-site, high-volume surgical ophthalmology model.
- Optegra: UK-headquartered ophthalmology hospital group operating dedicated eye care clinics across multiple countries, offering cataract surgery, laser vision correction, and retinal treatments — directly comparable service mix and multi-site clinic model to Veonet.
- Centre for Sight: UK private ophthalmology provider specializing in cataract, corneal, and refractive surgery with multiple clinic locations — comparable specialist eye-care clinic operator.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Veonet social profiles
Digital presenceVeonet financial estimates
Financial estimateRevenue estimate
Valuation estimate
Veonet leadership team
Management profileNumber of profiles
Profiles2 records
Veonet subsidiaries and ownership
Company hierarchySubsidiaries1 record
Veonet funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Veonet M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Veonet
What does Veonet do?
Veonet operates a Europe-wide network of eye care clinics providing a full spectrum of ophthalmology services to individual patients, including cataract surgery, glaucoma treatment, retinal care, and paediatric ophthalmology. The group delivers over 2.5 million consultations and 0.7 million surgical and treatment procedures per year through its clinic-based model, and supports clinical practice with AI-assisted diagnostic technology such as RetinSight AI.
Is Veonet a public or private company?
Veonet is a private company. It is classified as unknown and is currently operating.
When was Veonet founded?
Veonet was founded in 2021. It employs 1,001 to 5,000 people.
Where is Veonet based?
Veonet is headquartered in München, Germany, in the Europe region.
How does Veonet make money?
One revenue line is on record: ophthalmology Healthcare Services.
Who are Veonet's main competitors?
Broad incumbents on record are Carl Zeiss Meditec, Alcon, Moorfields Eye Hospital NHS Foundation Trust and Bausch + Lomb. Direct peers are Optimax, Clinica Baviera, Optical Express, Groupe Point Vision, Optegra and Centre for Sight.
Does Veonet have an API?
No public API is recorded for Veonet.
What industry is Veonet in?
Veonet's product category is Ophthalmology Healthcare Services. Its primary akta.pro industry code is HLAKAKAC, Ophthalmology Clinics (Medical & Surgical Eye Care), with a secondary code of HLAFAIAF, Ophthalmology Surgery Centers. Its NAICS code is 62231 and its SIC code is 8011.